QIM
CLVS

Quantitative Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Quantitative Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,584
Closed -$200K – 633
2021
Q1 		$200K Buy
+28,584
New +$192K 0.02% 458
2020
Q2 		– Sell
-100,054
Closed -$636K – 733
2020
Q1 		$636K Buy
+100,054
New +$803K 0.07% 284
2017
Q3 		– Sell
-77,800
Closed -$7.28M – 887
2017
Q2 		$7.28M Buy
+77,800
New +$4.76M 0.11% 239
2016
Q2 		– Sell
-28,000
Closed -$537K – 978
2016
Q1 		$537K Buy
+28,000
New +$593K 0.03% 538
2015
Q4 		– Sell
-62,400
Closed -$5.74M – 892
2015
Q3 		$5.74M Buy
+62,400
New +$5.4M 0.43% 52
2015
Q2 		– Sell
-3,000
Closed -$222K – 738
2015
Q1 		$222K Buy
+3,000
New +$212K 0.02% 551
2014
Q2 		– Sell
-5,400
Closed -$374K – 682
2014
Q1 		$374K Buy
5,400
+1,700
+46% +$125K 0.02% 394
2013
Q4 		$222K Buy
+3,700
New +$201K 0.02% 497

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantitative Investment Management's CLVS Position: Q2 2021 in Review

Quantitative Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 28,584 shares — an estimated $200K sold.

Quantitative Investment Management first reported a position in CLVS in Q4 2013 and held it in 8 quarters. The position peaked at $7.28M in Q2 2017. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • Quantitative Investment Management reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 28,584 Clovis Oncology, Inc. shares in Q2 2021, an estimated $200K.
  • Quantitative Investment Management first reported a position in Clovis Oncology, Inc. in Q4 2013 and held it in 8 quarters.
  • Quantitative Investment Management's Clovis Oncology, Inc. position peaked at $7.28M in Q2 2017.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Quantitative Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.